These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
542 related articles for article (PubMed ID: 19462934)
1. Atrial natriuretic peptide and brain natriuretic peptide release in human essential hypertension. Soualmia H; Ayadi I; Omar S; Feki M; Drissa H; Mebazaa A; Kaabachi N Clin Lab; 2009; 55(3-4):120-7. PubMed ID: 19462934 [TBL] [Abstract][Full Text] [Related]
2. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. Buckley MG; Markandu ND; Miller MA; Sagnella GA; MacGregor GA J Hum Hypertens; 1993 Jun; 7(3):245-50. PubMed ID: 8345491 [TBL] [Abstract][Full Text] [Related]
3. The concentration of atrial and brain natriuretic peptide in patients with idiopathic hypertension. Irzmanski R; Barylski M; Banach M; Piechota M; Kowalski J; Cierniewski C; Pawlicki L Med Sci Monit; 2007 Oct; 13(10):CR449-56. PubMed ID: 17901852 [TBL] [Abstract][Full Text] [Related]
4. Natriuretic peptides as markers of preclinical cardiac disease in obesity. Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331 [TBL] [Abstract][Full Text] [Related]
5. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy. Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441 [TBL] [Abstract][Full Text] [Related]
6. [Plasma levels of atrial and brain natriuretic peptide and left ventricular geometry in patients with essential hypertension]. Kosmala W; Spring A Pol Merkur Lekarski; 2003 Mar; 14(81):216-9. PubMed ID: 12914098 [TBL] [Abstract][Full Text] [Related]
7. [Atrial natriuretic peptide, left ventricular mass and renin-angiotensin-aldosterone system in essential arterial hypertension of a mild or moderate degree]. Gambini G; Talamonti D; Valori C G Ital Cardiol; 1992 Dec; 22(12):1397-403. PubMed ID: 1294423 [TBL] [Abstract][Full Text] [Related]
8. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor. Kohno M; Horio T; Yokokawa K; Yasunari K; Ikeda M; Minami M; Kurihara N; Takeda T Am J Med; 1995 Mar; 98(3):257-65. PubMed ID: 7872342 [TBL] [Abstract][Full Text] [Related]
9. B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients. Almeida P; Azevedo A; Rodrigues R; Dias P; Friões F; Vazquez B; Abreu-Lima C; Bettencourt P; Barros H Rev Port Cardiol; 2003 Mar; 22(3):327-36. PubMed ID: 12847875 [TBL] [Abstract][Full Text] [Related]
10. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation. Wozakowska-Kapłon B; Opolski G Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231 [TBL] [Abstract][Full Text] [Related]
12. New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy. Murakami Y; Shimada T; Inoue S; Shimizu H; Ohta Y; Katoh H; Nakamura K; Ishibashi Y Can J Cardiol; 2002 Dec; 18(12):1294-300. PubMed ID: 12518181 [TBL] [Abstract][Full Text] [Related]
13. Atrial and brain natriuretic peptides as markers of cardiac load and volume retention in primary aldosteronism. Kato J; Etoh T; Kitamura K; Eto T Am J Hypertens; 2005 Mar; 18(3):354-7. PubMed ID: 15797653 [TBL] [Abstract][Full Text] [Related]
14. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation. Engelmann MD; Niemann L; Kanstrup IL; Skagen K; Godtfredsen J Int J Cardiol; 2005 Oct; 105(1):31-9. PubMed ID: 16207542 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock. Ueda S; Nishio K; Akai Y; Fukushima H; Ueyama T; Kawai Y; Masui K; Yoshioka A; Okuchi K Shock; 2006 Aug; 26(2):134-9. PubMed ID: 16878020 [TBL] [Abstract][Full Text] [Related]
16. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters. Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342 [TBL] [Abstract][Full Text] [Related]
18. Brain and atrial natriuretic peptides: a dual peptide system of potential importance in sodium balance and blood pressure regulation in patients with essential hypertension. Buckley MG; Markandu ND; Sagnella GA; MacGregor GA J Hypertens; 1994 Jul; 12(7):809-13. PubMed ID: 7963510 [TBL] [Abstract][Full Text] [Related]
19. Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice. Buckley MG; Marcus NJ; Yacoub MH Clin Sci (Lond); 1999 Dec; 97(6):689-95. PubMed ID: 10585896 [TBL] [Abstract][Full Text] [Related]
20. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels. Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]